MRI Scan of patients implanted with MRI conditional Cardiac Rhythm Management system
Completed
- Conditions
- patients indicated for any one of the following: ICD / CRT-D / Pacemaker
- Registration Number
- CTRI/2017/05/008447
- Lead Sponsor
- St Jude Medical India Ltd
- Brief Summary
This is a prospective, multi-center clinical study designed to confirm the safety and effectiveness of St. Jude Medical low voltage pacemakers, high voltage dual chamber ICDs, and CRT-Ds with various leads in an MRI environment.
Total of 119 subjects enrolled across 14 investigational sites. The total duration of the study is 14 months. All Subjects were followed for 1 month following the MRI scan.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 88
Inclusion Criteria
- Eligible subjects will meet all of the following: • Are implanted with one of the following SJM device/lead combinations evaluated in this study for at least 60 days (can include patients with an eligible SJM lead for ≥ 60 days OR patients with a new eligible SJM pacemaker, ICD, or CRT device and eligible SJM lead implanted for at least 60 days: 1.
- Accent MRIâ„¢, Assurity MRIâ„¢, Endurity MRIâ„¢, or Endurity pacemaker with Tendrilâ„¢ STS Model 2088 lead 2.
- Accent MRIâ„¢, Assurity MRIâ„¢, Endurity MRIâ„¢, or Endurity pacemaker with IsoFlexâ„¢ Optim (Model 1944 or 1948) lead 3.
- Ellipseâ„¢ VR/DR or Fortify Assura VR/DR ICD with Tendrilâ„¢ STS (Model 2088) or Tendril MRIâ„¢ and Durataâ„¢ or Optisureâ„¢ leads 4.
- Quadra Assura™ CRT-D with Tendril™ STS (Model 2088), Durata™ or Optisure™, and Quartet™ Quadripolar leads • Are implanted with an eligible SJM pacemaker, ICD, or CRT-D device pectorally • Be willing to undergo an elective MRI scan without sedation.
- Note: Antianxiety agents (e.g. minor tranquilizers, etc.) may be used as long as the subject can communicate with site personnel during the MRI scan • Be able to provide informed consent for study participation (legal guardian is NOT acceptable) • Be willing and able to comply with the prescribed follow-up tests and schedule of evaluations.
Exclusion Criteria
- Subjects will be excluded if they meet any of the following: • Have another existing active implanted medical device, e.g., neurostimulator, infusion pump, etc.
- that has MR labeling that will not allow the MRI scans per this protocol to be completed.
- • Have other non-MRI compatible device or material implanted o NOTE: MRI compatible knee replacements, hip replacements, stents, etc.
- may be included as long as the labeling of these devices allow MRI scans conducted per this protocol o NOTE: MRI compatible mechanical, prosthetic, and bioprosthetic heart valves may be included as long as the labeling of these devices allow for MRI scans conducted per this protocol o NOTE: Non-removable dental implants may be included • Have a lead extender, adaptor, or capped/abandoned lead • Be unable to fit in MRI bore, i.e., subject will come into contact with the magnet façade inside the MRI bore.
- • Are currently participating in a clinical investigation that includes an active treatment arm • Are pregnant or planning to become pregnant during the duration of the study • Have a life expectancy of less than 3 months due to any condition • Meet exclusion criteria per local law (e.g. age).
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Freedom from MRI scan-related complications: one month following the MRI scan. one month post MRI scan
- Secondary Outcome Measures
Name Time Method Proportion of subjects with a capture threshold increase of less than 0.5V at 0.5 ms from pre MRI scan to one month post MRI scan one month post MRI scan
Trial Locations
- Locations (3)
Apollo Hospital, Chennai
🇮🇳Chennai, TAMIL NADU, India
Care Hospital,
🇮🇳Hyderabad, ANDHRA PRADESH, India
Fortis Escorts Heart Institute & Research Center
🇮🇳Delhi, DELHI, India
Apollo Hospital, Chennai🇮🇳Chennai, TAMIL NADU, IndiaDr A M KarthigesanPrincipal investigator91-8939177087drkarthigesan_am@apollohospitals.com